RIFAXIMIN TREATMENT INCREASES LACTOBACILLUS ABUNDANCE IN PATIENTS WITH DIFFERENT GASTROINTESTINAL AND LIVER DISEASES

(1) Internal Medicine and Gastroenterology,A Gemelli Hospital,Rome,Italy

(2) Institute of Microbiology,A Gemelli Hospital,Rome,Italy



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)

You may be interested in:

Is there a role for probiotics?
English, Presentation, Stomach & H. Pylori, Paediatrics, Young GI Track, 2018

Categorisation:

  • Format
    • Abstract
  • Year
    • 2015